Seth B. Coffelt
Impact in
- Immunology top 0.2%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Immunology 40
- Immune cells in cancer 22
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 7
- Oncology 27
- Cancer Immunotherapy and Biomarkers 10
- Chemokine receptors and signaling 8
- Co-authors
- Karin E. de VisserClaire E. LewisMax D. WellensteinCraig MurdochMunitta MuthanaCheei‐Sing HauKim VrijlandAline B. Scandurro
- Journals
- Cancer Research (4 papers)Nature reviews. Cancer (3 papers)PLoS ONE (3 papers)Journal of Clinical Investigation (2 papers)Nature (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Seth B. Coffelt
59 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Immunology 4.6k
- Oncology 3.6k
- Cancer Research 1.3k
- Genetics 634
- Microbiology 323
Countries citing papers authored by Seth B. Coffelt
This map shows the geographic impact of Seth B. Coffelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth B. Coffelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth B. Coffelt more than expected).
Fields of papers citing papers by Seth B. Coffelt
This network shows the impact of papers produced by Seth B. Coffelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth B. Coffelt. The network helps show where Seth B. Coffelt may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth B. Coffelt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 10 | |
| 5 | 2022 | 35 | |
| 6 | 2020 | 12 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 40 | |
| 9 | 2019 | 122 | |
| 10 | 2017 | 85 | |
| 11 | CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity | 2017 | 2 |
| 12 | 2015 | 112 | |
| 13 | 2014 | 34 | |
| 14 | 2012 | 2 | |
| 15 | 2012 | 38 | |
| 16 | 2011 | 101 | |
| 17 | 2011 | 186 | |
| 18 | 2010 | 268 | |
| 19 | 2009 | 69 | |
| 20 | The role of myeloid cells in the promotion of tumour angiogenesis Hit paper breakdown → | 2008 | 1251 |
About Seth B. Coffelt
Seth B. Coffelt is a scholar working on Immunology, Oncology, Microbiology, Obstetrics and Gynecology and Reproductive Medicine, having authored 62 papers that have together received 8.3k indexed citations. Recurring topics across this work include Immune cells in cancer (22 papers), Immune Cell Function and Interaction (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), T-cell and B-cell Immunology (9 papers), Chemokine receptors and signaling (8 papers), Immunotherapy and Immune Responses (7 papers), Antimicrobial Peptides and Activities (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Immunology (4.6k citations), Oncology (3.6k citations), Cancer Research (1.3k citations), Genetics (634 citations) and Microbiology (323 citations). Seth B. Coffelt has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Karin E. de Visser, Claire E. Lewis, Max D. Wellenstein, Craig Murdoch, Munitta Muthana, Cheei‐Sing Hau, Kim Vrijland, Aline B. Scandurro, Jos Jonkers and Metamia Ciampricotti. Their work appears in journals such as Cancer Research, Nature reviews. Cancer, PLoS ONE, Journal of Clinical Investigation and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.